tfr-1

TfR-1-IN-1 is a transferrin receptor 1 (TfR-1) inhibitor, also an Fe(III) salivary phenol complex, with anticancer activity. It induces apoptosis, inhibits the growth of tumor cells and normal cells, and is used in studies of leukemia.

Anti-Mouse/Rat CD71/TfR1 Antibody (OX-26) is a mouse-derived IgG2a, κ antibody inhibitor targeting CD71/TfR1 in mice and rats.

The Anti-Mouse CD71/TfR1 Antibody (R17 217.1.3) is a mouse-derived antibody originating from rat IgG2akappa, targeting CD71/TfR1. The isotype control for the Anti-Mouse CD71/TfR1 Antibody (R17 217.1.3) is RatIgG2akappa, Isotype Control.

The Anti-Mouse CD71/TfR1 Antibody (8D3) is an IgG2a antibody inhibitor derived from rats and targets mouse CD71/TfR1.

The isotype control subtype of anti-rat/mouse CD71/TfR1 antibody is Mouse IgG2a, κ.

The Anti-human CD71/TfR1 Antibody (JR-141 antibody (uncoupled from iduronate 2-sulfatase)) is a humanized antibody targeting the human transferrin receptor (CD71; TfR). It forms the antibody component of the fusion protein Pabinafusp alfa. The isotype control for the Anti-CD71/TfR1 Antibody can be referred to as Human IgG1 kappa, Isotype Control.

HAIYPRH hydrochloride is a targeting ligand that specifically binds to the transferrin receptor (TfR) and facilitates the transport of nanocarriers across the blood-brain barrier [1].

TfR-T12 TFA, a transferrin receptor (TfR)-binding peptide capable of crossing the blood-brain barrier (BBB), exhibits nanomolar (nM) binding affinity [1] [2].